Loading resource…

AIO and SAKK Study Working Groups
The DANTE trial started as a multicenter, randomized phase II trial, which was subsequently converted to a phase III trial. The document presents interim results focusing on surgical pathology and safety outcomes. It includes detailed data on surgical procedures, morbidity, and pathologic regression rates among patients receiving the treatment.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Exploring treatment options in cancer: tumor treatment strategies
Same clinical topic · Oncology

TUMOUR LYSIS SYNDROME
Same clinical topic · Oncology

SGLT2 INHIBITORS AND RISK OF DISTANT METASTASIS IN PATIENTS WITH BREAST CANCER AND TYPE 2 DIABETES: A TARGET TRIAL EMULATION WITH BIOLOGICAL PLAUSIBILITY ANALYSIS
Same clinical topic · Oncology

PERIOPERATIVE CHEMOTHERAPY WITH FLUOROURACIL PLUS LEUCOVORIN, OXALIPLATIN, AND DOCETAXEL VERSUS FLUOROURACIL OR CAPECITABINE PLUS CISPLATIN AND EPIRUBICIN FOR LOCALLY ADVANCED, RESECTABLE GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA (FLOT4): A
Same clinical topic · Oncology

NEOADJUVANT AND ADJUVANT PEMBROLIZUMAB PLUS CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC OR GASTRO OESOPHAGEAL CANCER (KEYNOTE-585): AN INTERIM ANALYSIS OF THE MULTICENTRE, DOUBLE-BLIND, RANDOMISED PHASE 3 STUDY
Same clinical topic · Oncology

HIV Associated Cancers and related diseases (2)
Same clinical topic · Oncology

UPDATE 2026: MANAGEMENT OF SMALL CELL LUNG CANCER
Same clinical topic · Oncology

HIV-Associated Cancers and Related Diseases
Same clinical topic · Oncology

HIV-Associated Cancers and Related Diseases
Same clinical topic · Oncology